These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 26193797)

  • 1. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
    Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
    Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.
    Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM
    Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer.
    Cho H; Lee YS; Kim J; Chung JY; Kim JH
    Cancer Invest; 2013 Nov; 31(9):607-15. PubMed ID: 24164300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer.
    Zhang J; Tang L; Shen L; Zhou S; Duan Z; Xiao L; Cao Y; Mu X; Zha L; Wang H
    Gynecol Oncol; 2012 Oct; 127(1):223-30. PubMed ID: 22721732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
    Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
    Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
    Wang JL; Yan TT; Long C; Cai WW
    Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
    Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
    J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.